COVID-19 and CIBS Center

Neurotropism of coronaviridae (CoVs) is known to have occurred in both SARS and MERS epidemics. SARS-CoV-2 closely shares the viral structure and pathobiology of SARS-CoV and MERS-CoV.

The intense cough, ventilator dyssynchrony, and infectious potential reported in COVID-19 patients begets management with large quantities of sedatives, immobilization and social isolation. Thus, COVID-19 is a perfect storm yielding an immense burden of delirium (which drives subsequent dementia) and PICS-related cognitive and mental health disabilities, leading to a widespread emerging public health crisis.

At the CIBS Center we will be studying the cognitive function and physical outcomes of COVID-19 survivors to understand the relationship between COVID-19 and long-term health from the pandemic. It may be that the dementia seen after critical illness, that we already study, could be made worse for COVID-19 patients.

COVID-19 United States Registry

The ARDS Foundation is collecting information about patients from the United States that have been tested and/or hospitalized for COVID-19. The purpose of collecting this information is so that in the future, research can be conducted relating to this epidemic.

Ongoing Research

CIBS Center’s COVID-19 Research

A national study (sponsored by NIH-NIA) in which deceased patients’ families are consenting to provide a priceless donation to science to study COVID-19 effect on the brain
A national study (sponsored by NIH-NIA) to understand long-term cognitive function, PTSD, and depression in COVID-19 survivors
An International study of the risk factors and epidemiology of delirium and coma in COVID-19 patients while admitted to the ICU
A national study of the effect of COVID-related isolation policies on patients, families, and healthcare providers in the ICU
A multicenter study of the role of a new drug for ICU delirium in COVID-19 patients
Speech Bubble

COVID-19 and CIBS Center in the News

Speech Bubble

Additional COVID-19 News